Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03926143
Title A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer



Anetumab ravtansine

Age Groups: adult | senior
Covered Countries USA | ITA | FRA

No variant requirements are available.